ASCARI, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.700
EU - Europa 2.371
AS - Asia 1.516
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
SA - Sud America 1
Totale 6.606
Nazione #
US - Stati Uniti d'America 2.684
CN - Cina 1.473
IE - Irlanda 788
UA - Ucraina 464
FI - Finlandia 312
SE - Svezia 267
DE - Germania 245
GB - Regno Unito 105
IT - Italia 83
FR - Francia 43
BE - Belgio 30
CA - Canada 16
IN - India 16
IR - Iran 14
NL - Olanda 12
AU - Australia 10
RU - Federazione Russa 9
DK - Danimarca 4
EU - Europa 4
HK - Hong Kong 3
RO - Romania 3
CZ - Repubblica Ceca 2
GR - Grecia 2
IQ - Iraq 2
JP - Giappone 2
MU - Mauritius 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
ES - Italia 1
ID - Indonesia 1
JO - Giordania 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TR - Turchia 1
VN - Vietnam 1
Totale 6.606
Città #
Dublin 787
Chandler 591
Jacksonville 570
Nanjing 452
Nanchang 191
Ashburn 164
Princeton 137
Hebei 125
Lawrence 125
Shenyang 124
Beijing 123
Medford 121
Changsha 113
Wilmington 112
Jiaxing 99
Ann Arbor 77
Helsinki 75
Hangzhou 70
Tianjin 70
Boardman 67
Milan 35
Woodbridge 33
Brussels 30
Norwalk 28
Verona 24
New York 20
Fairfield 19
Shanghai 16
Seattle 15
Toronto 15
Houston 12
Kunming 12
Jinan 10
Auburn Hills 9
Des Moines 9
Ningbo 8
San Genesio Ed Uniti 8
Los Angeles 7
Taizhou 7
Falls Church 6
Guangzhou 6
Orange 6
Zhengzhou 6
Andover 5
Ardabil 5
Fuzhou 5
Melbourne 5
Lanzhou 4
San Francisco 4
Pune 3
Rockville 3
Sacramento 3
Tappahannock 3
Washington 3
Arlington 2
Borås 2
Brno 2
Changchun 2
Chicago 2
Dearborn 2
Leawood 2
Naples 2
Pavia 2
Romainville 2
Tokyo 2
Adelaide 1
Amman 1
Amsterdam 1
Baghdad 1
Bari 1
Bridgeport 1
Canberra 1
Charlotte 1
Cupertino 1
Delhi 1
Desenzano Del Garda 1
Dhaka 1
Edmonton 1
Elphin 1
Groningen 1
Haikou 1
Hanoi 1
Hanover 1
Henderson 1
Inveruno 1
Karaganda 1
Kemerovo 1
Köln 1
Leidschendam 1
Maddingley 1
Munich 1
Newark 1
Novokuznetsk 1
Oslo 1
Pinehaven 1
Ponte Vedra Beach 1
Redwood City 1
San Jose 1
Santa Clara 1
Seelze 1
Totale 4.634
Nome #
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 84
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 83
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 79
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 79
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 79
Anomalous erythrocytes produced by rabbits with liver damage. 78
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 78
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 76
AMYLOIDOSIS AL 75
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 74
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 74
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 72
Acute phase proteins and prognosis in multiple myeloma. 71
Acute promyelocitic leukemia toluidine blue subtype. 70
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 70
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 69
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 68
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 68
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 68
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 66
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 66
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 66
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 66
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 65
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 64
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 64
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 64
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 63
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 63
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 62
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 61
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 61
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 61
Biologia e clinica del mieloma multiplo. 61
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 61
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 60
Glycopeptides of erythrocyte membranes in some hematological disorders 60
Anemie megaloblastiche. 60
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 60
Changing clinical presentation of multiple myeloma. 60
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 60
Acquired immune thrombastenia: a new bleeding disorder. 59
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 59
Possible evolution of human parvovirus B19 infection into erythroleukemia 58
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 58
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 57
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 57
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 57
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 56
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 56
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 56
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 55
Applicazioni cliniche dei fattori di crescita emopoietici. 55
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 54
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 54
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 53
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 52
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 52
Applicazioni cliniche della citometria. 52
Membrane sialic acid and behaviour in vivo of rabbit "stress" macroreticulocytes. 52
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 52
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 51
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 50
Acute promyelocytic leukemia: morphological and clinical features. 50
Terapia del mieloma multiplo. 50
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 50
Flow cytometric analysis of paraffin embedded material in human gastric cancer. 49
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 49
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 49
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 49
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 48
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 48
Cytokinetic studies on circulating neoplastic cells of Hodgkin's disease. 48
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 48
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 48
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 48
New approaches to cancer chemotherapy. 47
Il trattamento del carcinoma mammario. 47
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 47
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma 46
Multilineage dysplasia without increased blasts identifies a poor prognosis subset of myelodysplastic syndromes. 46
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 46
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 46
Chemotherapy-induced leukonychia 46
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 45
Fisiopatologia dell'eritrocito. 45
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 45
Erythrocyte membrane modifications in chronic granulocytic leukaemia 44
Silymarine during maintenance therapy of acute promyelocytic leukemia. 44
IL MIELOMA MULTIPLO 44
Oral idarubicin and prednisone for advanced, previously untreated multiple myeloma: a pilot study. 44
Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes 44
Post remission chemotherapy in adult non lymphoblastic leukemia: results of two protocols including intensive or non-intensive consolidation therapy. 44
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 43
Loss of the Y chromosome in smoldering acute leukemia. 43
Tecniche citochimiche e citocinetiche. 42
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 42
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 42
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 42
Bone marrow morphology and proliferative activity in acquired immunodeficiency syndrome. 42
Totale 5.694
Categoria #
all - tutte 20.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019117 0 0 0 0 0 0 0 0 95 7 2 13
2019/20201.790 518 750 0 88 0 96 14 95 6 159 64 0
2020/2021875 92 71 32 84 7 129 3 134 32 137 117 37
2021/2022650 9 1 21 10 24 35 12 35 23 32 88 360
2022/20231.924 217 129 21 136 183 174 3 87 880 11 57 26
2023/2024516 82 94 25 65 64 133 15 32 6 0 0 0
Totale 6.680